Table 4
Ixodes scapularis studies: mean live tick counts per group and efficacy results
Study | n | Arithmetic means (AM) of live ticks and % efficacy1 on indicated days | |||||
---|---|---|---|---|---|---|---|
I. scapularis #1 | Day 2 | Day 9 | Day 16 | Day 23 | Day 32 | ||
Control group2 | 8 | AM | 26.5 | 27.9 | 30.4 | 32.1 | 32.5 |
Treated group3 | 8 | AM | 1.3 | 0.2 | 0.0 | 0.4 | 0.0 |
% efficacy4 | 95.1 | 99.3 | 100.0 | 98.8 | 100.0 | ||
I. scapularis #2 | Day 2 | Day 9 | Day 16 | Day 22 | Day 32 | ||
Control group2 | 10 | AM | 24.5 | 26.5 | 27.2 | 24.4 | 22.2 |
Treated group3 | 10 | AM | 0.3 | 0.0 | 0.0 | 0.1 | 0.4 |
% efficacy4 | 98.8 | 100.0 | 100.0 | 99.6 | 98.2 |
Note: p-values5 for comparison of the untreated and treated groups = <0.0001 at all time-points.
n = number of cats per group.
The I. scapularis counts were analyzed using SAS Version 9.4. The logarithm of the (count + 1) was analyzed at each study day separately using the MIXED procedure with treatment group used as a fixed effect and blocks used as a random effect.
Treated group = Novel formulation administered topically once on Day 0 at 0.12 mL/kg, providing 1.4 mg/kg esafoxolaner, 10.0 mg/kg praziquantel and 0.5 mg/kg eprinomectin
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.